Fair Value Calculator Fair Value Calculator
EN DE

AST (AST) Fair Value & Analysis

Consumer Defensive · Market cap 1.2B PLN

A AST AST · WAR
Price46.10 PLN
Fair Value16.20 PLN
Upside-64.9%
Quality47/100
Watch AST for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range 15.08 PLN – 19.81 PLN

Fair value as of: Jun 24, 2026

From 16 valuation models · updated 8 days ago

Fair value updated Jun 24, 2026 — revised from 15.11 PLN to 16.20 PLN (+7.2%) since Jun 23, 2026. Share price +1.1% over the past month.

Price vs Fair Value (12 months)

56.55 PLN 41.30 PLN Fair Value 16.20 PLN Jun 2025 Jul 2026

12‑month range 41.30 PLN – 56.55 PLN · fair‑value band 15.08 PLN – 19.81 PLN · the 46.10 PLN price screens above the 16.20 PLN fair value. As of Jun 24, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

AST (AST) currently trades at 46.10 PLN, while our model-based Fair Value estimate is 16.20 PLN — implying the stock looks roughly 64.9% overvalued today. We read business quality at 47/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, AST generated revenue of 23.5B PLN at a net margin of -0.1%. Revenue grew 23.1% year over year. It earns a return on equity of -0.1%. Net debt stands at 94.0M PLN. Fundamentals as of Jun 24, 2026

Key figures & financial health

Revenue (TTM) 23.5B PLN
Revenue growth (YoY) +23.1%
Net margin -0.1%
Return on equity -0.1%
Free cash flow −65.7M PLN FY2025
P/E ratio 234.0
More key figures
EPS (TTM) 0.2100 PLN
EPS growth (YoY) -94.6%
Net debt 94.0M PLN FY2025

Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

AST reported revenue of 472M PLN in FY2025 versus 491M PLN in FY2021, a compound −1.0%/yr. Reported net income was 19.9M PLN in FY2025, compounding −36.5%/yr from FY2021.

Revenue −1.0%/yr
FY21 491M PLN
FY22 510M PLN
FY23 619M PLN
FY24 612M PLN
FY25 472M PLN
Net income −36.5%/yr
FY21 122M PLN
FY22 65.2M PLN
FY23 58.3M PLN
FY24 83.2M PLN
FY25 19.9M PLN

Is AST fairly valued? → Check now

Similar stocks

6 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).

Stock Price Fair Value vs Fair Value
Archer-Daniels-Midland Company ADM $83.37 $35.54 -57%
MHP SE MHPC $0.0872 $0.0100 -89%
Muyuan Foods Group 002714 ¥34.43 ¥49.23 +43%
Bunge Global SA BG $111.42 $67.10 -40%
2714 2714 HK$31.94 HK$52.68 +65%
Tyson Foods, Inc TSN $56.13 $46.40 -17%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is AST (AST) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 16.20 PLN versus a price of 46.10 PLN — about −65% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AST?
Our model-based fair value for AST is 16.20 PLN (as of Jun 24, 2026), built from audited fundamentals. The current price is 46.10 PLN.
What is the quality score of AST?
AST has a Quality Score of 47/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of AST (AST)?
AST reported trailing-twelve-month revenue of about 23.5B PLN (latest available figure, as of Jun 24, 2026).
What is the net profit margin of AST?
The net profit margin of AST is about -0.1%, meaning it is currently running at a net loss. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.